Katsutoshi Kokubun

Title: Innovations by Katsutoshi Kokubun in Cancer Detection

Introduction

Katsutoshi Kokubun is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of cancer research through his innovative work on peptides that bind to epithelial cell adhesion molecules (EpCAM). His research aims to enhance the detection and diagnosis of cancer cells, which is crucial for improving patient outcomes.

Latest Patents

Kokubun holds a patent for "Peptides that bind to epithelial cell adhesion molecule." The primary objective of this invention is to provide a novel peptide with a high ability to bind to EpCAM. This peptide can be easily synthesized using chemical methods or genetic engineering techniques. The invention improves upon existing methods for screening phage libraries, allowing for the successful identification of peptides that exhibit superior binding capabilities compared to previously known peptides. The peptides developed through this research demonstrate at least ten times higher binding ability to EpCAM, making them effective tools for cancer detection and diagnosis.

Career Highlights

Katsutoshi Kokubun is affiliated with the Japanese Foundation for Cancer Research, where he continues to advance his research in cancer diagnostics. His work has garnered attention for its potential impact on early cancer detection, which is vital for effective treatment strategies.

Collaborations

Kokubun collaborates with notable colleagues, including Kiyotaka Shiba and Kanako Suga. Their combined expertise contributes to the innovative research being conducted at the Japanese Foundation for Cancer Research.

Conclusion

Katsutoshi Kokubun's contributions to cancer research through his patented peptides represent a significant advancement in the field. His work not only enhances the understanding of EpCAM binding but also holds promise for improving cancer detection methods.